Peripheral blood monocytes from polar lepromatous leprosy (LL) patients were unable to support Mycobacterium leprae-induced in vitro lymphoproliferation of HLA-D-matched T cells from tuberculoid leprosy subjects, whereas those from responder individuals were able to do so. Monocyte-rich Adherent cells with macrophage/monocyte characteristics have been implicated in the immunological unresponsiveness associated with a wide variety of infections. Macrophages alone or in combination with T cells have been shown to suppress antibody synthesis and proliferative responses to specific antigens, mitogens, and alloantigens in experimental animals infected with African trypanosomiasis (9), Mycobacterium lepraemurium (4, 36), and Mycobacterium bovis (12). Peripheral blood-derived monocytes from patients with tuberculosis (7), sarcoidosis (11), schistosomiasis (21), disseminated fungal infection (29) , and diffuse cutaneous leishmaniasis (23) were also reported to inhibit antigen-or mitogen-induced lymphoproliferation. There is growing evidence that mycobacteria may cause suppression of immune responses through the release of soluble factors from suppressor lymphocytes and macrophages (31, 35) .
Peripheral blood monocytes from polar lepromatous leprosy (LL) patients were unable to support Mycobacterium leprae-induced in vitro lymphoproliferation of HLA-D-matched T cells from tuberculoid leprosy subjects, whereas those from responder individuals were able to do so. Monocyte-rich adherent cells from untreated LL patients released de novo soluble factors which inhibited antigeninduced lymphoproliferation to a greater extent and mitogenic responses to a lesser extent. Suppressive activity varied in different LL patients. However, the degree of suppression was similar in soluble factors obtained de novo and after treatment of adherent cells with heat-killed and freshly extracted, cryopreserved M. leprae. Treated patients showed less inhibition with de novo released soluble factors (27 ± 7.7%) as compared to parallel soluble factors obtained after antigen treatment (44 ± 4.8%) or with de novo soluble factors from untreated LL patients (62 ± 14.2%). Similar supernatants from tuberculoid individuals showed no or insignificant effects on antigen-induced lymphoproliferation. The suppressive activity of LL soluble factors was produced for up to 72 h, was heat stable at 56°C for 30 min, was indomethacin resistant, and resided in the >25,000 molecular weight fraction.
Adherent cells with macrophage/monocyte characteristics have been implicated in the immunological unresponsiveness associated with a wide variety of infections. Macrophages alone or in combination with T cells have been shown to suppress antibody synthesis and proliferative responses to specific antigens, mitogens, and alloantigens in experimental animals infected with African trypanosomiasis (9) , Mycobacterium lepraemurium (4, 36) , and Mycobacterium bovis (12) . Peripheral blood-derived monocytes from patients with tuberculosis (7), sarcoidosis (11) , schistosomiasis (21) , disseminated fungal infection (29) , and diffuse cutaneous leishmaniasis (23) were also reported to inhibit antigen-or mitogen-induced lymphoproliferation. There is growing evidence that mycobacteria may cause suppression of immune responses through the release of soluble factors from suppressor lymphocytes and macrophages (31, 35) .
It is well established that Mycobacterium leprae infection leading to disseminated lepromatous leprosy is associated with poor T cell functions. These patients have been consistently shown to have poor delayed hypersensitivity reactions and reduced blastogenic and antigenic responses in vitro (16, 32) . In contrast, tuberculoid leprosy individuals show optimal responses in similar assays. The mechanisms underlying immunological unresponsiveness in lepromatous leprosy have received recent attention. Having observed repeatedly that suppressor T cell activity was not a conspicuous feature in most untreated lepromatous individuals studied by us (17) (18) (19) 28) as well as others (5, 27, 30) , we thought it pertinent to investigate the role of peripheral blood monocytes in this disease, using a lymphoproliferative assay with enriched T cell populations.
The present study confirms the earlier findings (19) and indicates that whereas monocytes from tuberculoid leprosy individuals supported M. leprae-induced responses of HLA-D identical responder T-enriched cells, those from lepromatous patients were unable to do so. Moreover, monocytes from lepromatous subjects released soluble factors which inhibited antigenand mitogen-induced lymphoproliferation. The monocyte suppressive factors were released for up to 3 days of the culture period, were heat stable, and were not affected by indomethacin treatment. la  TT  T cells  AW30, B13, W6, CW6, DRW7/A2, BW40.2 W6, DRW2  TT  Monocyte  -dolb  TT  T cells  A3, BW5, W6, CW3, DRW2/All, BW51, W4, DRW4  TT  Monocytes  -dolc  TT  T cells  AW30, B13, W6, CW6, DRW7/A2, BW40.2, W6, DRW2  TT  Monocytes  A3, BW5, W6, CW3, DRW2/A1l, BW51, W4, DRW4  ld  TT?  T cells  AW30, B13, W6, CW6, DRW7/A2, BW40 (6) . These patients had received treatment with 100 mg of dapsone daily for 3 to 5 years. Lepromatous patients had residual bacilli in the skin.
The other patients were drawn from the Hansen's clinics of the All-India Institute of Medical Sciences and Safdarjang Hospital, New Delhi, and were 28 untreated lepromatous leprosy patients (27 male and 1 female) who were bacillary positive (bacillary index [24] ranging from 4+ to 6+), 22 untreated tuberculoid patients (20 male and 2 female), and 5 male lepromatous patients treated for 5 to 7 years with dapsone as described above who had a bacillary index of 1 +. All patients were graded on the basis of Ridley-Jopling classification (25) 42, 1983 on September 29, 2017 by guest http://iai.asm.org/ Downloaded from cult) and suspended in RPMI 1640 (GIBCO-Biocult) buffered with 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (GIBCO-Biocult) and supplemented with 100 U of penicillin per ml, 100 jig of streptomycin per ml, and 10% pooled AB serum (complete medium).
(i) Adherent cells. Adherent cells were isolated from PBMC on 24-well tissue culture plates (Flow Laboratories, Irvine, Scotland) which had been precoated with fetal calf serum (GIBCO-Biocult). 106 PBMC per well were incubated for 2 h at 37°C in an atmosphere of 5% CO2 and air. The nonadherent cells were removed by washing five times with warm Hanks balanced salt solution. The adherent cells were removed by further incubating the monolayers with 12 mM xylocaine (Astra-IDL, Bangalore, India) in RPMI 1640 plus 10%o fetal calf serum for 45 min at 37°C, washed two times, and suspended in complete medium.
(ii) Nylon wool column-purified cells. Two-milliliter syringes were packed with 40 mg of nylon wool (Leuko-pak; Fenwall Laboratories, Morton Grove, Ill.), and 10 x 106 nonadherent cells were added to prewashed, prewarmed columns. The columns were incubated for a further 1 h at 37°C, and the cells were removed by dropwise elution with 4 x 1 ml of RPMI 1640 plus 10% fetal calf serum.
MoF(s). Adherent cells obtained from 1 x 106 PBMC per ml per well were overlaid with 1.25 x 106 M. Ieprae and incubated at 37°C for 24 h in a humidified atmosphere containing 5% CO2 and air. Subsequently, supernatants were collected, centrifuged at 400 x g for 5 min, filtered through 0.45-,um membranes (Millipore Corp., Bedford, Mass.), and stored at -20°C. In the experiments involving time kinetics, 24 (ii) MoF(s). Quadruplicate cultures containing 105 PBMC in 50 ,ul of complete medium and 50 ,ul of MoF(s) with and without 25 RI1 of soluble AB40-pokeweed mitogen-concanavalin A were set up in microculture plates. Mitogen-and antigen-stimulated cultures were harvested on days 3 and 6, respectively, as described above.
Characterization of factor(s). Indomethacin (Sigma) was dissolved in 0.1 M Na2CO3 as 20 mg/ml and diluted in RPMI 1640 to 100 ,ug/ml. Ten micrograms of indomethacin was added to each well containing adherent cells derived from 106 PBMC. The cultures were treated with and without antigen, and supernatants were collected as described above.
MoF(s) collected without serum were centrifuged in Amicon ultrafiltration membrane cones (CFT 25; Amicon Corp., Lexington, Mass.) which retained constituents with a molecular weight above 25,000. The sepa- Statistical analysis was done by using Mann-Whitney's U test (1 from paired tuberculoid individuals (Fig. 1) 4 were used at the same concentration for evaluation of suppressive activity. In total, MoF(s) from 28 untreated, 5 treated lepromatous, and 6 tuberculoid patients were assayed on lymphoproliferative responses of 3 responder healthy individuals and 16 tuberculoid patients.
(i) Dose response. Figure 3 shows dose-related inhibition of antigen-induced lymphoproliferation of PBMC in cultures containing 10, 25, and 50 ,ul of factors from two lepromatous patients. The addition of such factors to PBMC alone had no or an insignificant effect on basal DNA synthesis (Fig. 3, inset) . Suppressive activity was not observable at 1 and 2 ,ul. In subsequent assays 50 ,lI of MoF(s) was used.
(ii) Antigen-induced lymphoproliferation. Monocytes from lepromatous patients consistently released suppressive factors de novo (Table 2 and Fig. 4 ). Significant suppression of antigen-induced lymphoproliferation ranging from 37 to 87% was observed in cultures of PBMC from tuberculoid patients in the presence of MoF(s) derived from 12 untreated lepromatous patients. The addition of either type of antigens did not significantly enhance the suppressive effect. The percentage of suppression varied from individual to individual but was within the same range for all three types of factors derived from the same patient. Suppression was observed regardless of the type of M. leprae antigen used for lymphoproliferation (data not shown). Interestingly MoF(s) from five treated lepromatous leprosy patients showed lower de novo suppressive effects (27 ± 7.7%) as compared to parallel supematants from antigentreated cells (44 ± 4.8%) and de novo factors from untreated lepromatous leprosy patients (62 ± 14.2%) (Fig. 4) .
in contrast, similar supernatants derived from tuberculoid patients showed no suppressive effects. In some instances such factors had mild stimulatory effects on antigen-stimulated PBMC of tuberculoid individuals (Fig. 4 and Table 2) but none on T cells or nonadherent cells of lepromatous subjects (data not shown).
Mitogen-induced lymphoproliferation. MoF(s) derived from nine lepromatous patients also showed significant suppression of concanavalin A-and pokeweed mitogen-induced blastogenesis of PBMC from healthy individuals ( Table 3 ).
The degree of inhibition was, however, of a lower order compared to the suppression noted in antigen-stimulated lymphocyte cultures. VOL. 42, 1983 on September 29, 2017 by guest http://iai.asm.org/ (Table 4) .
(ii) Heat stability. Suppressive activity was heat stable at 56°C for 30 min (Table 5 ) and on immersion in boiling water for 1 min (data not shown).
(iii) Molecular size. Twenty-four-hour de novo released MoF(s) from serum-depleted cultures derived from five lepromatous patients were centrifuged in ultrafiltration membrane cones which excluded particles of molecular weight <25,000 (antigen-treated supernatants were avoided to preclude the effects, if any, of soluble antigens leached from prefrozen or heat-killed M. leprae). It may be observed from Fig. 5 that the fraction with molecular weight >25,000 showed inhibition of lymphoproliferation to levels observed with unfractionated MoF(s). Fractions below 25,000 were nonsuppressive and permitted lymphoproliferation to the same order as that obtained in control antigen-stimulated PBMC cultures without MoF(s).
(iv) Effect of indomethacin. The addition of indomethacin, a potent inhibitor of prostaglandin synthesis, failed to abrogate the suppressive effects of MoF(s) from four lepromatous patients (Fig. 6 ). Unstimulated control PBMC, when incubated with similar supernatants, did not show any alteration in basal DNA synthesis (Fig. 6, inset) . DISCUSSION Earlier studies from various laboratories (5, 27, 30) , including ours (17) (18) (19) 28) , had failed to find a causal relationship between suppressor T cell activity and the immunological unresponsiveness observed in lepromatous leprosy. In the present study, using cocultures of T-enriched and monocyte-rich cell fractions from HLA-D-defined paired individuals, it was found that monocytes from lepromatous patients were unable to support M. leprae-induced lympho- 15 refer to cultures left uninterrupted after a change of medium at 72 h. (10) and refuted by others (30) . Evidence from our study (15) and other studies (14, 33) antigen-treated monocyte supernatants. The possibility of intracellular bacilli in the circulation of these patients influencing the production of suppressive factors cannot be excluded. However, patients treated for 5 to 7 years who harbored decreased numbers of residual bacilli in the skin showed lower suppressive effects, particularly in the de novo supernatants. Since all the factors had been filtered through 0.45-,m Millipore membranes, particulate antigens were not considered to be contributing to the suppressive activity. Monocytes from tuberculoid leprosy patients treated in a similar manner showed a conspicuous absence of suppressive factors. The suppressive activity of the MoF(s) from lepromatous patients had a molecular weight of >25,000 and was heat stable, indomethacin resistant, and continuously produced for up to 72 h.
In recent years, MoF(s) have been reported in guinea pigs and mice infected with Mycobacterium tuberculosis (34) and BCG (31) . In the former experimental model, spontaneous release of suppressive factors was observed, a feature similar to ours. Such factors associated with human adherent cells treated with many species of mycobacteria, including M. leprae, have also been shown to inhibit blastogenesis, protein synthesis, and lymphokine production of lymphocytes (26, 35) .
Monocyte/macrophage factors rich in thymidine (20) , arginase (13), interferon (22) , and prostaglandins (8) have been reported to have suppressive effects on lymphoproliferative responses. The presence of thymidine and other low-molecular-weight compounds can be ruled out in our system, in which suppression was observed exclusively in the molecular weight ranges above 25,000. However, our present studies cannot conclusively rule out either interferon-or prostaglandin-related suppression. Although indomethacin treatment failed to abrogate the suppressive effects, the observed de novo production of suppressive factors could suggest the possibility of an in vivo induction of prostaglandin whose effects would not be abrogated by the later in vitro addition of indomethacin. Similarly, although prostaglandins are lowmolecular-weight compounds, their presence in micellar form cannot be excluded.
The present results suggest the possibility that suppressive factors released from the peripheral blood monocytes of lepromatous patients play a significant role in the immunological unresponsiveness associated with this disease. Whether the release of these factors is influenced by T cells, and conversely, whether these factors function through other suppressive cells requires further elucidation. It would be of considerable importance to determine whether the macrophages in the lesions also release such suppressive factors and whether this suppression could be abrogated by immunological manipulation.
